SCP
RDY icon

Sivia Capital Partners’s Dr. Reddy's Laboratories RDY Stock Holding History

Sivia Capital Partners’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$345K Buy
23,802
+7,068
+42% +$95.4K 0.04% 432
2026
Q1 		$232K Sell
16,734
-8,025
-32% -$112K 0.04% 401
2025
Q4 		$348K Buy
24,759
+1,047
+4% +$14.7K 0.07% 366
2025
Q3 		$331K Sell
23,712
-692
-3% -$9.96K 0.09% 285
2025
Q2 		$367K Sell
24,404
-6,723
-22% -$96K 0.12% 215
2025
Q1 		$411K Buy
31,127
+629
+2% +$8.68K 0.19% 100
2024
Q4 		$482K Sell
30,498
-312
-1% -$4.69K 0.24% 62
2024
Q3 		$490K Sell
30,810
-325
-1% -$5.23K 0.29% 58
2024
Q2 		$474K Buy
31,135
+4,445
+17% +$63.7K 0.32% 50
2024
Q1 		$392K Buy
26,690
+150
+0.6% +$2.19K 0.27% 68
2023
Q4 		$369K Buy
+26,540
New +$355K 0.28% 66

Other funds holding RDY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
AIM
Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Sivia Capital Partners's RDY Position: Q2 2026 in Review

Sivia Capital Partners increased its Dr. Reddy's Laboratories (RDY) stake by 42% in Q2 2026, buying an estimated $95.4K and bringing the position to 23,802 shares worth $345K. The position accounts for 0.04% of the portfolio, ranked #432.

Sivia Capital Partners first reported a position in RDY in Q4 2023 and has held it in 11 quarters since. The position peaked at $490K in Q3 2024. 238 funds tracked by Wall St. Rank hold RDY as of Q2 2026.

  • Sivia Capital Partners held 23,802 shares of Dr. Reddy's Laboratories worth $345K as of Q2 2026.
  • Sivia Capital Partners bought 7,068 Dr. Reddy's Laboratories shares in Q2 2026, an estimated $95.4K.
  • Dr. Reddy's Laboratories made up 0.04% of Sivia Capital Partners's portfolio in Q2 2026, its #432 holding.
  • Sivia Capital Partners first reported a position in Dr. Reddy's Laboratories in Q4 2023 and has held it in 11 quarters since.
  • Sivia Capital Partners's Dr. Reddy's Laboratories position peaked at $490K in Q3 2024.
  • 238 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2026.

Based on Sivia Capital Partners's 13F filing for Q2 2026, filed 23 Jul 2026.